JP2005506276A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506276A5 JP2005506276A5 JP2002551990A JP2002551990A JP2005506276A5 JP 2005506276 A5 JP2005506276 A5 JP 2005506276A5 JP 2002551990 A JP2002551990 A JP 2002551990A JP 2002551990 A JP2002551990 A JP 2002551990A JP 2005506276 A5 JP2005506276 A5 JP 2005506276A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- antiallergic
- pharmaceutical composition
- allergic
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 30
- 230000003266 anti-allergic effect Effects 0.000 claims 21
- 239000000043 antiallergic agent Substances 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 16
- 210000003630 histaminocyte Anatomy 0.000 claims 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 125000004122 cyclic group Chemical group 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 108010062307 AAVALLPAVLLALLAP Proteins 0.000 claims 4
- 206010027654 Allergic conditions Diseases 0.000 claims 4
- 206010020751 Hypersensitivity Diseases 0.000 claims 4
- 208000030961 allergic reaction Diseases 0.000 claims 4
- 238000005452 bending Methods 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 230000001747 exhibiting effect Effects 0.000 claims 4
- 210000003491 skin Anatomy 0.000 claims 4
- 238000011200 topical administration Methods 0.000 claims 4
- 210000004899 c-terminal region Anatomy 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 206010019233 Headaches Diseases 0.000 claims 2
- 208000005615 Interstitial Cystitis Diseases 0.000 claims 2
- 102000001253 Protein Kinase Human genes 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- 208000024780 Urticaria Diseases 0.000 claims 2
- 201000009961 allergic asthma Diseases 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 231100000869 headache Toxicity 0.000 claims 2
- 208000028774 intestinal disease Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 239000000816 peptidomimetic Substances 0.000 claims 2
- 108060006633 protein kinase Proteins 0.000 claims 2
- 230000001107 psychogenic effect Effects 0.000 claims 2
- 102000043136 MAP kinase family Human genes 0.000 claims 1
- 108091054455 MAP kinase family Proteins 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000028709 inflammatory response Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL14047300A IL140473A0 (en) | 2000-12-21 | 2000-12-21 | Anti-allergic complex molecules |
| PCT/IL2001/001186 WO2002050097A2 (en) | 2000-12-21 | 2001-12-20 | Anti-allergic complex molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506276A JP2005506276A (ja) | 2005-03-03 |
| JP2005506276A5 true JP2005506276A5 (enExample) | 2005-12-22 |
Family
ID=11074953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002551990A Ceased JP2005506276A (ja) | 2000-12-21 | 2001-12-20 | 抗アレルギー複合体分子 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7112568B2 (enExample) |
| EP (2) | EP1891975A1 (enExample) |
| JP (1) | JP2005506276A (enExample) |
| AU (2) | AU1738402A (enExample) |
| CA (1) | CA2432879A1 (enExample) |
| IL (1) | IL140473A0 (enExample) |
| WO (1) | WO2002050097A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL130526A0 (en) * | 1999-06-17 | 2000-06-01 | Allergene Ltd | Novel anti-allergenic agents |
| US20070009544A1 (en) * | 1999-06-17 | 2007-01-11 | Ronit Eisenberg | Anti-allergic complex molecules |
| IL140473A0 (en) * | 2000-12-21 | 2002-02-10 | Allergene Ltd | Anti-allergic complex molecules |
| JP4498101B2 (ja) * | 2004-11-04 | 2010-07-07 | 大鵬薬品工業株式会社 | 頭痛の予防及び／または治療剤 |
| DE602007011202D1 (de) | 2006-01-27 | 2011-01-27 | Univ Wuerzburg J Maximilians | Peptid zur hemmung von calcineurin |
| WO2010137012A1 (en) | 2009-05-25 | 2010-12-02 | Ramot At Tel-Aviv University Ltd. | Peptide therapy for amphiregulin mediated diseases |
| WO2011038397A2 (en) * | 2009-09-28 | 2011-03-31 | Duke University | Peptide adjuvants, vaccines, and methods of use |
| US9730921B2 (en) | 2012-03-27 | 2017-08-15 | Duke University | Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage |
| US9492544B2 (en) * | 2013-04-11 | 2016-11-15 | Vanderbilt University | Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders |
| US11571455B2 (en) | 2013-04-11 | 2023-02-07 | Vanderbilt University | Methods and compositions for treating alcoholic liver disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3987192A (en) * | 1974-01-07 | 1976-10-19 | The Upjohn Company | Compositions and process of treatment |
| US5807746A (en) | 1994-06-13 | 1998-09-15 | Vanderbilt University | Method for importing biologically active molecules into cells |
| US6103692A (en) | 1996-03-12 | 2000-08-15 | The General Hospital Corporation | Inhibiting protein interactions |
| IL130526A0 (en) * | 1999-06-17 | 2000-06-01 | Allergene Ltd | Novel anti-allergenic agents |
| IL140473A0 (en) | 2000-12-21 | 2002-02-10 | Allergene Ltd | Anti-allergic complex molecules |
-
2000
- 2000-12-21 IL IL14047300A patent/IL140473A0/xx unknown
-
2001
- 2001-12-20 EP EP07022899A patent/EP1891975A1/en not_active Withdrawn
- 2001-12-20 AU AU1738402A patent/AU1738402A/xx active Pending
- 2001-12-20 JP JP2002551990A patent/JP2005506276A/ja not_active Ceased
- 2001-12-20 CA CA002432879A patent/CA2432879A1/en not_active Abandoned
- 2001-12-20 AU AU2002217384A patent/AU2002217384B2/en not_active Ceased
- 2001-12-20 WO PCT/IL2001/001186 patent/WO2002050097A2/en not_active Ceased
- 2001-12-20 EP EP01271384A patent/EP1478378A4/en not_active Withdrawn
-
2003
- 2003-06-20 US US10/465,826 patent/US7112568B2/en not_active Expired - Fee Related
-
2005
- 2005-08-29 US US11/214,588 patent/US7528110B2/en not_active Expired - Fee Related
-
2009
- 2009-03-27 US US12/412,646 patent/US20090227768A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11911447B2 (en) | Peptide pharmaceuticals for insulin resistance | |
| CN105451755B (zh) | 铁调素类似物和其用途 | |
| CN104684576B (zh) | 聚乙二醇化的oxm变体 | |
| Harms et al. | An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation | |
| EP2709645B1 (en) | Improved peptide pharmaceuticals | |
| ES2544573T3 (es) | Inhibidores diméricos de afinidad elevada de PSD-95 y su uso para el tratamiento del daño cerebral isquémico y del dolor | |
| JP2017523959A (ja) | ヘプシジンおよびミニ−ヘプシジンアナログおよびその使用 | |
| RU2014126484A (ru) | Нацеленные соединения лизосомальных ферментов | |
| JP2011518179A5 (enExample) | ||
| JP2005506276A5 (enExample) | ||
| CN116018349A (zh) | 抗感染的双环肽配体 | |
| CN110300595A (zh) | Pac1受体激动剂(maxcap)及其用途 | |
| JP2003500456A (ja) | 角質細胞増殖因子−２製剤 | |
| Abbood | Insights into Therapeutic Peptides and their Quality Control | |
| CN113383005A (zh) | 靶向线粒体疾病的类似物 | |
| US11299518B2 (en) | Fusion respiratory syncytial virus inhibitors and use thereof | |
| TW201808346A (zh) | 長效調酸素調配物及其產生與投與方法 | |
| CN110267979A (zh) | Erfe融合多肽组合物及使用方法 | |
| JP2008502323A5 (enExample) | ||
| US20100298213A1 (en) | Pharmaceutically Active Insulin Receptor-Modulating Molecules | |
| CN116157140A (zh) | 具有肾酶促效剂活性的稳定胜肽 | |
| CN105936646A (zh) | 迷你蛋白及其应用 | |
| US20210236597A1 (en) | Methods and compositions for treating and diagnosing polycystic ovary syndrome | |
| DK1960515T3 (da) | Inflammationshæmmende peptider | |
| EP4650362A1 (en) | Neuroprotective psd-95 polypeptide inhibitor and use thereof |